Connor, Clark & Lunn Investment Management (CC&L)
PROF

Connor, Clark & Lunn Investment Management (CC&L)’s Profound Medical PROF Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-76,200
Closed -$572K – 1565
2024
Q4 		$572K Sell
76,200
-700
-0.9% -$5.38K ﹤0.01% 1107
2024
Q3 		$612K Buy
+76,900
New +$695K ﹤0.01% 1039

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s PROF Position: Q1 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Profound Medical (PROF) in Q1 2025, closing a stake of 76,200 shares — an estimated $572K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in PROF in Q3 2024 and held it in 2 quarters. The position peaked at $612K in Q3 2024. 49 funds tracked by Wall St. Rank hold PROF as of Q1 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Profound Medical position as of Q1 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 76,200 Profound Medical shares in Q1 2025, an estimated $572K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Profound Medical in Q3 2024 and held it in 2 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Profound Medical position peaked at $612K in Q3 2024.
  • 49 funds tracked by Wall St. Rank held Profound Medical as of Q1 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.